gastroesophageal cancer
Castle Biosciences Builds Skin Cancer Assay Data, Eyes Future Expansion as Q1 Sales Jump 74 Percent
Premium
The company highlighted clinical research progress for its two skin cancer tests and said it hopes to expand in the gastrointestinal cancer space in coming years.
Agilent, Transcenta Ink CDx Development Deal for Stomach Cancer Therapy Trial
The immunohistochemistry assay will be used to aid patient selection for a Phase III clinical trial of osemitamab plus Opdivo (nivolumab) and chemotherapy.
Thermo Fisher Scientific Gets FDA Clearance for Neuroendocrine Cancer Assay
The BRAHMS CgA II KRYPTOR immunoassay is for use to track tumor progression for neuroendocrine cancer patients by measuring CgA concentration in serum.
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors
Palmetto has expanded the local coverage determination for the Guardant360 liquid biopsy assay to be used with the majority of advanced solid tumors.